Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIO-RAD LABORATORIES, INC. Director's Dealing 2017

Sep 11, 2017

30786_dirs_2017-09-11_3e266131-cb87-4e13-a9a4-381c8e7f0653.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIO RAD LABORATORIES INC (BIO, BIOB)
CIK: 0000012208
Period of Report: 2017-09-08

Reporting Person: Magni Giovanni (EVP, Chief Strategy Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2017-09-08 Bio-Rad A Common Stock M 400 Acquired 10943 Direct
2017-09-08 Bio-Rad A Common Stock F 151 $218.42 Disposed 10792 Direct
2017-09-10 Bio-Rad A Common Stock M 400 Acquired 11192 Direct
2017-09-10 Bio-Rad A Common Stock F 151 $218.42 Disposed 11041 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2017-09-08 Restricted Stock Units $0 M 400 Disposed Bio-Rad A Common Stock (400) Direct
2017-09-10 Restricted Stock Units $0 M 400 Disposed Bio-Rad A Common Stock (400) Direct

Footnotes

F1: Shares of Class A common stock acquired on the vesting of restricted stock units.

F2: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.

F3: The restricted stock units vest in five equal annual installments beginning September 8, 2017.

F4: The restricted stock units vest in five equal annual installments beginning September 10, 2015.